[ad_1]
The discovery of a new drug for the treatment of Alzheimer's disease and the loss of millions of Arab Net
BEIJING (Reuters) – The US pharmaceutical group Peugeot and its Japanese partner Isai have decided to terminate two late – stage clinical trials of adocanumab for the treatment of Alzheimer 's disease as part of the program. a reversion of the disease.
[ad_2]Source link
